FDA Adverse Event Injury Summary report: N

GYNECARE PROLIFT TOTAL PELVIC FLOOR REPAIR SYSTEM

MDR report key: 3181060 · Received June 20, 2013

Report

Report Number
2210968-2013-10687
Event Type
Injury
Date Received
June 20, 2013
Report Date
August 12, 2016
Manufacturer
ETHICON INC.
Product Code
OTP
PMA / PMN Number
K013718
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). CONCLUSION: NO CONCLUSION CAN BE DRAWN AT THIS TIME. SHOULD ADDITIONAL INFORMATION BE OBTAINED, A SUPPLEMENTAL 3500A FORM WILL BE SUBMITTED ACCORDINGLY.

Additional Manufacturer Narrative · 1

(B)(4). REASON FOR SURGERY: SUI, CYSTOCELE . CONCURRENT PROCEDURES: PERIVAGINAL DEFECT REPAIR, CYSTOCELE REPAIR. IT WAS REPORTED THAT FOLLOWING INSERTION PATIENT EXPERIENCED URINARY/BOWEL PROBLEMS, RECURRENCE, DYSPAREUNIA, INFECTION, AND BLEEDING. IT WAS REPORTED THAT PATIENT UNDERWENT EXCISION WITH REVISION OF CYSTOCELE ON (B)(6) 2006 DUE TO EXTRUSION.

Additional Manufacturer Narrative · 1

DATE SENT TO THE FDA: (B)(4) 2013. IN ADDITION, A REVIEW OF THE BATCH MANUFACTURING RECORDS WAS CONDUCTED AND THE BATCH MET ALL FINISHED GOODS RELEASE CRITERIA.

Additional Manufacturer Narrative · 1

IT WAS REPORTED THAT THE PATIENT UNDERWENT REVISION SURGERY ON (B)(6) 2006 DUE TO EXTRUDED MESH BY (B)(6).

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT UNDERWENT A GYNECOLOGICAL PROCEDURE ON (B)(6) 2006 AND MESH WAS IMPLANTED. IT WAS REPORTED THAT SHE EXPERIENCED PAIN, EROSION OF HER INTERNAL BODILY TISSUE AND OTHER INJURIES FOLLOWING THE PROCEDURE. IT WAS REPORTED THAT THE PATIENT HAS UNDERGONE MULTIPLE SURGERIES AND REVISIONARY PROCEDURES. NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
280873 GYNECARE PROLIFT TOTAL PELVIC FLOOR REPAIR SYSTEM MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC OTP ETHICON INC. UNK 1396900

Patients

Seq Age Sex Outcome Treatment
1 57 YR Required Intervention